Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01329705

Dynamic Splinting for Plantarflexion in Spastic Hemiplegia

Dynamic Splinting for Excessive Plantarflexion in Patients With Spastic Hemiplegia: A Randomized, Controlled Study of Gait Analysis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Dynasplint Systems, Inc. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effectiveness of onabotulinum toxin A (BTX) injections (tone management) and dynamic splinting (contracture reduction) for improving gait patterns in patients with spastic hypertnoia due to stroke or traumatic brain injury and resultant excessive plantarflexion.

Conditions

Interventions

TypeNameDescription
DEVICEAnkle Dorsiflexion DynasplintDynamic splinting utilizes the protocols of Low-Load Prolonged Stretch (LLPS) with calibrated adjustable tension to increase Total End Range Time (TERT)to reduce contracture. The Dynasplint or "Experimental" group will add this therapy to their standard of care regimen
OTHERStandard of carePatients will begin a 12 week course of physical therapy with once-weekly therapy appointment, focusing on: * range of motion stretching of the Achilles tendon, hamstrings, hip flexors and any other tight musculature * strengthening of tibialis anterior to allow dorsiflexion in swing phase of gait as well as strengthening of other weak musculature * gait training to improve heel strike and toe off, stride length, and gait progression * sensory, proprioceptive training in foot position and degree of plantarflexion or dorsiflexion * no electric stimulation (e-stim) will be utilized

Timeline

Start date
2011-05-01
Primary completion
2015-05-01
Completion
2015-08-01
First posted
2011-04-06
Last updated
2013-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01329705. Inclusion in this directory is not an endorsement.